Cardiorespiratory fitness and digestive cancer mortality: findings from the Aerobics Center Longitudinal Study (ACLS) by Peel, J. Brent et al.
University of South Carolina
Scholar Commons
Faculty Publications Epidemiology and Biostatistics
4-2009
Cardiorespiratory fitness and digestive cancer
mortality: findings from the Aerobics Center
Longitudinal Study (ACLS)
J. Brent Peel
University of South Carolina - Columbia
Xuemei Sui
University of South Carolina - Columbia
Charles E. Matthews
Swann Arp Adams
University of South Carolina - Columbia, adamss@mailbox.sc.edu
James R. Hébert
University of South Carolina - Columbia, jhebert@sc.edu
See next page for additional authors
Follow this and additional works at: https://scholarcommons.sc.edu/
sph_epidemiology_biostatistics_facpub
Part of the Public Health Commons
This Article is brought to you by the Epidemiology and Biostatistics at Scholar Commons. It has been accepted for inclusion in Faculty Publications by
an authorized administrator of Scholar Commons. For more information, please contact dillarda@mailbox.sc.edu.
Publication Info
Postprint version. Published in Cancer Epidemiology, Biomarkers and Prevention, Volume 18, Issue 4, 2009, pages 1111-1117.
Peel, J.B., Sui, X., Matthews, C.E., Adams, S.A., Hébert, J.R., Hardin, J.W., Church, T.S., & Blair, S.N. (2009). Cardiorespiratory fitness
and digestive cancer mortality: findings from the Aerobics Center Longitudinal Study (ACLS). Cancer Epidemiology, Biomarkers and
Prevention, 18(4), 1111-1117. doi: 10.1158/1055-9965.EPI-08-0846
© 2009 American Association for Cancer Research.
http://cebp.aacrjournals.org/content/18/4/1111.long
Author(s)
J. Brent Peel, Xuemei Sui, Charles E. Matthews, Swann Arp Adams, James R. Hébert, James W. Hardin,
Timothy S. Church, and Steven N. Blair
This article is available at Scholar Commons: https://scholarcommons.sc.edu/sph_epidemiology_biostatistics_facpub/29
Cardiorespiratory fitness and digestive cancer mortality: findings
from the Aerobics Center Longitudinal Study (ACLS)
J. Brent Peel1, Xuemei Sui1,*, Charles E. Matthews2, Swann A. Adams3,4, James R.
Hébert3,4, James W. Hardin3,5, Timothy S. Church6, and Steven N. Blair1,3
1 University of South Carolina, Arnold School of Public Health, Department of Exercise Science, Columbia,
SC
2 Vanderbilt University Medical Center, Institute for Medicine and Public Health, Vanderbilt-Ingram Cancer
Center, Nashville, TN
3 University of South Carolina, Arnold School of Public Health, Department of Epidemiology and
Biostatistics, Columbia, SC
4 Statewide Cancer Prevention and Control Program, University of South Carolina, Columbia, SC
5 University of South Carolina, Center for Health Services and Policy Research, Columbia, SC
6 Pennington Biomedical Research Center, Baton Rouge, LA
Abstract
Although higher levels of physical activity are inversely associated with risk of colon cancer, few
prospective studies have evaluated overall digestive system cancer mortality in relation to
cardiorespiratory fitness (CRF). The authors examined this association among 38,801 men aged 20
−88 years and who performed a maximal treadmill exercise test at baseline in the Aerobics Center
Longitudinal Study (Dallas, Texas) during 1974−2003. Mortality was assessed over 29 years of
follow-up (1974−2003). 283 digestive system cancer deaths occurred during a mean 17-year of
observation. Age-adjusted mortality rates per 10,000 person-yrs according to low, moderate, and
high CRF groups were 6.8, 4.0, and 3.3 for digestive system cancer (trend p < 0.001). After adjustment
for age, examination year, body mass index, smoking, drinking, family history of cancer, personal
history of diabetes, hazard ratios for overall digestive cancer deaths (95% confidence interval) for
those in the middle and upper 40% of the distribution of CRF relative to those in the lowest 20%
were 0.66 (0.49, 0.88) and 0.56 (0.40, 0.80), respectively. Being fit (the upper 80% of CRF) was
associated with a lower risk of mortality from colon (0.61 [0.37, 1.00]), colorectal (0.58 [0.37, 0.92]),
and liver cancer (0.28 [0.11, 0.72]), compared with being unfit (the lowest 20% of CRF). These
findings support a protective role of CRF against total digestive tract, colorectal, and liver cancer
deaths in men.
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Digestive system cancers include those of the alimentary canal below the neck (e.g., esophagus,
stomach, small and large intestines) and key digestive organs (i.e., pancreas, liver, gallbladder).
Considering all digestive cancers together, these constitute the second leading cause of cancer-
related mortality of men in the United States (1). Of all digestive tract sites, colon and pancreas
account for the majority of deaths (colon because it is so common and pancreas because it has
such poor prognosis). The etiology of various digestive cancers is not fully understood. Several
potential risk factors including genetic components, diet, smoking, and physical inactivity have
been identified for colon cancer (2). However, other than smoking and diabetes (3,4), few
lifestyle factors have been linked to pancreatic cancer. Recent evidence suggests insulin
resistance and abnormal glucose metabolism, without diagnosis of diabetes also may be risk
factor for pancreatic cancer (5,6).
Although higher levels of physical activity are inversely associated with risk of colon cancer
(7,8), the association between pancreatic cancer and physical activity remains inconclusive.
Several studies have found an inverse relationship (9,10) while other studies have reported no
association (11-13). Very few cohort studies have reported on physical activity and other sites
of digestive system cancer, and the findings are inconsistent (14,15). No studies have been
conducted to assess the association between physical activity and cancers from liver or small
intestine. There is some indication that greater amounts of activity are associated with higher
risk of stomach (14) and bladder (15) cancer and lower risk of oral/oesophagus cancer (15). It
may be that measurement errors inherent in self-reported physical activity are partly
responsible for these discrepant findings. Cardiorespiratory fitness (CRF), an objective and
more reproducible measure, reflects the functional consequences of physical activity habits of
the individual, and therefore may provide a better exposure with which to evaluate associations
with relevant health outcomes.
To the best of our knowledge, only one study (16) has been conducted on CRF and mortality
from cancers of the gastrointestinal system among men. However, this study only examined
men with pre-diabetes and diabetes. There is lack of data in the general population. Because
the five-year survival rate for digestive cancers as a group is very low (about 45%; and <10%
for some sites such as pancreas and esophagus), identification of modifiable risk factors for
these deadly cancers may provide important opportunities for reducing overall cancer mortality
(17). We therefore examined the association between the CRF, objectively measured by
maximal exercise test on a treadmill, and overall and site-specific digestive cancer mortality
in men from the Aerobic Center Longitudinal Study (ACLS). We tested the hypothesis that
CRF is associated with cancers of colorectum, pancreas, esophagus, stomach or gall bladder
for which there is prior evidence of an association (7-10,14,15), and generated hypotheses on
the association between cancers of the liver or small intestine and either CRF or other measures
of physical activity for which there are no prior data.
Materials and Methods
Study population. The ACLS is an ongoing cohort study of patients who were each examined
during a preventive medical examination in Dallas, Texas, between 1974 and 2003. This study
was reviewed and approved by the Cooper Institute Institutional Review Board on an annual
basis. The sample for the current analysis was 38,801 primarily white, well-educated, middle-
to-upper socioeconomic status men aged 20−88 years. The inclusion criteria required men had
no prior history of cancer, ulcer disease, gallbladder trouble, jaundice, hepatitis, cirrhosis, or
colon polyps. At baseline, all participants completed a symptom limited treadmill test. The
men in the analyses reported here are very similar to the overall ACLS cohort, with only minor
differences in some clinical variables. The death rate for the subgroup of men in this analysis
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is not significantly different from the age, risk factor, health status, and family history-adjusted
rates for the overall cohort.
Baseline examination. Participants arrived for the clinical examination after an overnight fast
of at least 12 hours and gave their written informed consent to participate in the examination
and the follow-up study. Information was collected pertaining to personal and family health
histories, fasting blood chemistry analyses, anthropometry, resting blood pressure and
electrocardiogram, and a maximal graded exercise test. Examination methods and procedures
followed a standard manual of operations, as described previously (18). Briefly, body mass
index (BMI) was computed from measured height and weight (kg/m2). Resting blood pressure
was recorded as the first and fifth Korotkoff sounds by ausculatatory methods. Serum samples
were analyzed for lipids and glucose using standardized automated bioassays by a laboratory
that participates in the CDC Lipid Standardization Program and meets its quality control
standards. Information on smoking habits (never, past, and current smoker), alcohol intake
(number of drinks per week), personal history of diabetes, and family (from parents and
siblings; i.e., first-degree relatives) history of cancer from all-cause was obtained from a
standardized questionnaire. One unit of alcohol is defined as 12 ounces (3.41 dl) of beer, 5
ounces (1.421 dl) of wine, or 1.5 ounces (0.4262 dl) of hard liquor.
We determined CRF at the baseline examination using a maximal exercise test on a treadmill.
CRF was assessed as the duration of the exercise test using a modified Balke protocol (18,
19). The treadmill speed was 88m • min−1 for the first 25 min. During this time the grade was
0% for the first minute, 2% the second minute and increased 1% for each minute. After 25 min,
the grade remained constant while the speed increased 5.4 m • min−1 each minute until test
termination. Patients were encouraged to give a maximal effort during the test. Men included
in the present analyses reached at least 85% of their age-predicted maximal heart rate (220-
age [years] beats per minute) on the test. The duration of the maximal exercise treadmill test
on this protocol is highly (and positively) correlated with directly measured maximal oxygen
uptake in men (20) (r = 0.92), an accepted measure of CRF. Maximal metabolic equivalents
(METs, 1 MET = 3.5 ml O2 uptake • kg−1 • min−1) were estimated from the final treadmill
speed and grade (21). We used our previously published age-specific distribution of treadmill
duration from the overall ACLS population to define fitness groups as low (lowest 20%),
moderate (middle 40%), and high (upper 40%) to maintain consistency in the study methods,
and because we have found that a low level of fitness, defined in this way, is an independent
predictor of mortality (18,22) and morbidity (23). The respective cut points for total treadmill
time and METs in the low, moderate, and high fitness groups were described in detail in a
recent report (23).
Ascertainment of digestive cancer death. All participants were followed from the date of their
baseline examination until their date of death or December 31, 2003. The National Death Index
(NDI) was the primary data source for mortality surveillance. The NDI has been shown to be
an accurate method of ascertaining deaths in observational studies, with high sensitivity (96%)
and specificity (100%) (24). The underlying cause of death was determined from the NDI report
or by a nosologist's review of official death certificates obtained from the department of vital
records in the decedent's state of residence. Causes of cancer death were identified using
International Classification of Diseases, Ninth Revision (ICD-9) codes for deaths occurring
before 1999 and Ten Revision (ICD-10) codes (in parentheses) for deaths during 1999−2003.
Our primary outcome for this analysis was death from digestive cancers, 150−159 (C15-C26);
and our secondary mortality outcomes were: esophagus, 150 (C15); stomach, 151 (C16); small
intestine, 152 (C17); colon, 153 (C18); rectum, 154 (C19-C21); liver, 155 (C22); gall bladder
and intrahepatic bile ducts, 156 (C23-C24); pancreas, 157 (C25); and other and ill-defined
digestive organs, 158−159 (C26).
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Statistical analysis. Baseline characteristics of the population were calculated for the entire
study group and by CRF categories. Differences in covariates were assessed using F-tests.
Kaplan-Meier plots were used to compare survival curves. The crude and multivariate adjusted
log-rank tests were used to determine significance. Cox proportional hazards models were used
to estimate adjusted hazard ratios (HRs), associated 95% confidence intervals (CIs), mortality
rates (deaths/10,000 person-years of follow-up), and linear trends of mortality for levels of
each fitness category. When calculating HRs, the low fitness group was used as the reference
category. Multivariable-adjusted models controlled for the potential confounding effects of
baseline age (years), examination year, smoking (never, past, or current smoker), alcohol intake
(drinks per week), and family history of cancer (whether present). Examination year was
included as a covariate to control for variation in the length of follow-up in this on-going study.
We conducted additional analyses that further adjusted for baseline differences in two factors
that could plausibly mediate the association between CRF and digestive cancer mortality: BMI
(<25 vs. ≥25 kg/m2), and diabetes (whether diagnosed prior to, or at the examination).
Unfortunately, we have no information on nonsteroidal anti-inflammatory drug (NSAIDs)
usage to include in the model. Cumulative hazard plots grouped by exposure had no appreciable
violations of the proportional hazards assumption.
Next, we conducted Cox-regression analyses of CRF stratified by categories of BMI (< 25 vs.
≥ 25 kg/m2). We also examined the risk of total digestive system cancer across increments of
METs to assess the shape of the fitness-mortality curve. Finally, we explored the site-specific
cancer deaths across fitness levels. Statistical analyses were performed using SAS (version 9.1,
SAS Institute, Cary, NC) software. All p values were calculated based on two-sided hypothesis
tests, and CIs were calculated at the 95% level.
Results
At baseline, the mean (SD) age of the study participants was 43.8 (9.7) years, the mean treadmill
test duration was 17.9 (5.2) minutes, and the mean CRF measure was 11.6 (2.5) METs. The
distribution of participant characteristics for several digestive cancer risk factors is given in
Table 1 across categories of CRF. Men in the high-fitness group were more likely to have a
lower BMI, to have more favorable lipid and blood pressure profiles, to be non-smokers, and
to have less diabetes, compared to men with low CRF. The Kaplan-Meier plot depicts the total
digestive cancer death rates by fitness group (Fig. 1). After adjusting for all the risk factors,
the resulting log-rank test did not change materially (Chi-square=14.9, p <0.001).
In a mean length of 17 years follow-up and 661,169 person-years of observation, 283 total
digestive cancer deaths were identified. A steep inverse gradient (p trend <0.001) of total
digestive cancer mortality rates was observed across CRF groups (Table 2). After adjusting
for potential confounders (age, examination year, smoking status, alcohol intake, family history
of cancer), men with moderate and high CRF had 37 and 49 % lower risk of death from digestive
cancers, respectively, than did men with low CRF (p trend < 0.001). Additional adjustment for
BMI and personal history of diabetes did not materially change the magnitude or the pattern
of the association.
To explore possible effect modification of the association between CRF and total digestive
cancer by BMI, we stratified the analysis according to BMI category (<25 and ≥25 kg/m2)
(Table 2). The age-adjusted death rate was inversely related to CRF within the normal weight
(18.5<BMI<25kg/m2) (p trend = 0.009) and overweight/obese (BMI≥25 kg/m2) (p trend = 0.003,
because of the small number of deaths (only 1 death) in obese (BMI≥30 kg/m2) men with high
CRF, we combined the overweight and obese groups). Similar patterns of association were
noted after adjusting for confounders.
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To examine the dose-response characteristics between CRF levels and total digestive cancer
mortality in our population of men, we computed the age-adjusted death rates (per 10,000
person-yrs) for categories of CRF defined by increments of 1 MET across the range of 7 to 14
METs (Fig. 2). An exercise capacity of less than 8 METs was associated with a more than 3
fold higher risk of total digestive cancer mortality compared with men having a capacity of 11
METs and greater (p trend <0.001). Across incremental MET levels (from <7.0 to ≥14.0 METs),
the covariates (including BMI and diabetes)-adjusted HRs of mortality were 1.0, 0.75 (0.43
−1.30), 0.48 (0.30−0.76), 0.39 (0.23−0.66), 0.43 (0.26−0.71), 0.36 (0.21−0.63), 0.38 (0.21
−0.69), 0.28 (0.15−0.53), and 0.38 (0.19−0.76), p trend <0.001. Excluding the first five-year of
follow-up did not materially change the magnitude and the pattern of the association (p trend
<0.001).
Because of the small number of site-specific cancer deaths and the similar trends in total
digestive cancer mortality across fitness levels, the moderate- and high-fit groups were
combined into one group (fit) and the low-fit group (unfit) was used as the referent (Fig. 3).
For all digestive system cancers combined, the adjusted mortality risk associated with being
fit was 0.62 (95% CI: 0.47, 0.82). Being fit was associated with a lower risk of mortality from
colon cancer (0.61 [0.37, 1.00]), colorectal cancer (0.58 [0.37, 0.92]), and liver cancer (0.28
[0.11, 0.72]). The associations between fitness and small intestine, gall bladder, and pancreatic
cancer were suggestive of a reduced risk, but the hazard ratios did not reach statistical
significance (0.36 [0.02, 6.61]; 0.83 [0.09, 7.74], and 0.75 [0.45, 1.24], respectively).
Because baseline age may influence results, we conducted additional sensitivity analyses by
repeating the above analysis in men with baseline age 35−74 years (N=32,137). The patterns
of the association between fitness and digestive cancer mortality across different baseline age
ranges were similar (data not shown).
Discussion
In this study, we observed an inverse association between CRF and the risk of total digestive
cancer mortality, with men in the moderate and high CRF groups demonstrating a 34% and
44% lower risk, respectively, of dying of digestive cancers after adjustment of confounding
by age, smoking, drinking, and family history of cancer. Excluding men with pre-diabetes and
diabetes did not materially change the results. Men with an exercise capacity less than 8 METs
had a more than 3-fold higher risk of dying of digestive cancer as compared with those with
higher METs level (≥11). These data suggest that an exercise capacity of at least 8 METs may
be needed to provide substantially protective benefits.
To the best of our knowledge, only one previous study has assessed the association of CRF to
risk of dying of digestive cancer (16). However, that paper examined the role of CRF and risk
of fatal digestive cancer events in men with pre-diabetes or diabetes, whereas our paper
examined a much broader male population. Our results were similar to the previous paper's
findings and show that higher levels of CRF are associated with substantially lower risk of
dying from digestive cancers (including colorectal and liver cancers). In that study, Thompson
and colleagues (16) found that being fit, as defined by achieving at least a moderate level of
fitness during a maximal exercise test, had a 45% lower risk of digestive cancer mortality. In
our study, we found that men with at least a moderate fitness level had a 34% lower digestive
cancer risk than did men with low CRF. In our study, it appeared that beyond a CRF level of
8 METs (Fig. 2) there were no substantial decreases in risk of digestive cancer death. This
finding of an apparent CRF threshold adds insight into the association between CRF and
digestive cancer death. Although CRF has a genetic component (25−40%) (25,26), it is clear
that usual physical activity habits are the primary determinant of fitness. CRF can be enhanced
in most individuals through participation in moderate and vigorous physical activities, such as
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brisk walking, bicycling, and jogging, for 30 minutes or more on most days of the week (about
8-kcal/kg per week) (27). This consensus public health recommendation will produce a
maximal capacity of at least 8 METs in most individuals.
Our finding of an inverse association between physical activity and colorectal risk is consistent
with evidence from previous studies (28-30). A previous meta-analysis estimated an
approximately 20−40% lower risk of colon cancer for high versus low leisure-time physical
activity (29). In our study, we found men with at least a moderate fitness level had a 42% lower
risk of death from colorectal cancer than did men with low CRF.
We did not observe a significant inverse association between CRF and mortality from
pancreatic cancer, a finding which is consistent with many studies (12,13,16,31-35), but
discrepant from others (9,10,36). However, we did observe a 25% reduction in mortality at this
site among more fit men, but the small number of deaths limited the precision of our estimates.
Given that the strength of the CRF-pancreatic cancer association was somewhat weaker than
the risk estimates we observed for colorectal and liver cancer mortality (HR=0.28 to 0.58), it
may be that the association between pancreatic cancer and activity-related exposure is weaker.
Since physical activity is a complex behavior and often imprecisely measured in epidemiologic
studies, the combination of exposure measurement error and a weaker association may account
for the heterogeneity in previous reports using self-reported physical activity as the exposure.
We speculate that these two factors may be contributing to the inconsistency in previous
findings. Future studies will be warranted to further explore this issue and confirm the present
findings.
Little information is available on the association between physical activity or CRF and other
types of digestive cancer. In this study, higher fitness was shown to be associated with
significantly lower risk of liver cancer. This is consistent with the findings among men with
pre-diabetes and diabetes (16). The findings with regard to stomach cancer have not been
consistent. We found an inverse trend on stomach cancer as well as in men with diabetes
(16), though the trend was not statistically significant, possibly due to the small number of
deaths. The British Regional Heart Study (BRHS) found the same nonsignificant inverse trend
between physical activity and stomach cancer (15). In contrast, the Japanese Hawaiian Cancer
Study (JHCS) found increased activity to be associated with higher risk of stomach cancer but
the results were preliminary (14). Only one previous study reported a lower risk of oral/
oesophagus cancer with moderate vigorous activity (15). We observed a similar trend.
Regarding bladder cancer, neither JHCS (14) nor the current study found any association
between activity and urinary bladder cancer, however, BRHS (15) showed significant increase
in risk of bladder cancer among men who were vigorously active. Finally, we observed a non-
statistically significant lower risk of small intestine cancer among men with high fitness.
Despite the absence of a prior hypothesis for the sites shown in Fig. 3, fitness appeared to be
protective overall. These findings may provide clues for future research, in studies having
larger sample sizes and employing rigorous methods of measuring fitness (such as we had
available to us).
Several biological mechanisms have been proposed to explain how higher levels of physical
activity may protect against cancer in general and cancers of the digestive tract in particular.
Physical activity is known to effect cancer development through immune system function,
insulin sensitivity, and growth factor levels (37-39). It is unclear which mechanisms are
important for different sites of digestive cancer. Any or all of these mechanisms may influence
general susceptibility to cancer (38). There are links between colorectal cancer and central
obesity (40,41) and insulin and the insulin-like growth factor (e.g., IGF-1) axis (42).
Biologically, it appears that insulin resistance and abnormal glucose metabolism may be related
to increased risk of pancreatic cancer. We specifically examined two potential obesity-related
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mediators of the association (BMI and diabetes) in our sequential models, and found that
adjustment for these factors had relatively little influence on the strength of associations
observed. This finding suggests adiposity and diabetes, as measured in our study, are not strong
mediators of the associations of interest. Evidence suggests that higher plasma glucose levels
after an oral glucose load is predictive of pancreatic cancer mortality (5) as is a diagnosis of
diabetes (4). However, little is known about the specific mechanisms between physical activity
and stomach, small intestine, liver, bladder and other digestive tract cancers. Potential
mechanisms, specific to gastrointestinal health, include decreased fecal transit time, reduced
bile secretion, altered prostaglandin synthesis, and gut flora (43). Additional research is needed
to clarify the complicated association between activity and digestive tract cancers.
This large prospective study with a long follow-up interval has a number of strengths that
should be considered. First, it is rare to have a measure of fitness in a prospective study of
digestive cancer mortality. Second, our extensive baseline examination to evaluate health status
(such as cancer and diabetes), careful measurement of body-size, and other lifestyle factors
addresses the potential for confounding by these factors to influence our results. Our study also
has limitations that should be considered. First, we are unable to adjust for dietary factors such
as fiber and saturated fat intake in the current study. Second, while we had a hard endpoint of
digestive cancer mortality, it is not possible to determine completely whether higher levels of
CRF protected men against developing cancer, or whether it aided their survival after their
diagnosis. However, the low 5-year survival rates for many of these cancers (especially,
pancreatic and liver cancer) make incidence and mortality essentially interchangeable (as
virtually everyone diagnosed with the cancer dies of the cancer) (44). Fitness also appeared to
be protective against esophagus, stomach, small intestine, and gall bladder cancer mortality,
even though statistical significance was not achieved because of the small number of deaths
associated with these sites. Third, few studies have examined the relationship between physical
activity to cancer risk in anatomic segments of the colon with conflicting results (45).
Unfortunately we do not have data regarding specific subsite colon cancer risk. Another
limitation to the current findings is that the study population consists mainly of white men in
the middle and upper socioeconomic strata; thus results may not be generalizable to other adult
populations, but should not affect the internal validity of our findings. In terms of exposure
assessment, we classified men at study enrollment, but in the present analysis we were unable
to evaluate the impact of changes in fitness over time on our outcomes. It is possible, but not
very likely, that many low-fit men increased their fitness levels at some point in the follow-up
interval. Additionally, others may have experienced decreases in this component. Therefore,
we can not examine whether changes in fitness and other exposures occurred during follow-
up. However, such misclassification of exposure would likely lead to and underestimate of the
magnitude of the association observed in the present study. We had insufficient information
in order to assess the effect of aspirin and other NSAIDs on outcome. Future studies should
include such information whenever possible.
In summary, the findings from this study provide evidence supporting a protective role of CRF
on risk of digestive cancer mortality and that a relatively low, threshold of CRF may be needed.
The consensus public health guideline to obtain 150 min/week of moderate-intensity physical
activity will improve their fitness levels and produce this threshold in most individuals. Given
the public health burden of digestive cancer, future research needs to determine the specific
biological characteristics of exercise related to digestive cancer risk, and if a dose-response
relationship exists.
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Kaplan-Meier plots for mortality due to total digestive system cancer, Aerobics Center
Longitudinal Study, Dallas, Texas, 1974−2003. CRF, cardiorespiratory fitness.
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Age- adjusted mortality rates (per 10,000 man-years) of total digestive system cancer by
cardiorespiratory fitness levels quantified in 1-MET increments obtained during a maximal
treadmill test in men, Aerobics Center Longitudinal Study, Dallas, Texas, 1974−2003. Number
at risk (and number of cases) in <7.0, 7.0−7.9, 8.0−8.9, 9.0−9.9, 10.0−10.9, 11.0−11.9, 12.0
−12.9, 13.0−13.9, and ≥14.0 was 859 (33), 1,096 (27), 4,465 (53), 4,135 (33), 6,014 (44), 5,827
(30), 5,180 (25), 5,872 (20), and 5,353 (18).
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Risk of site-specific digestive cancer mortality associated with being fit (the upper 80% of the
distribution of CRF) as defined by achieving at least a moderate level of fitness during maximal
exercise testing, Aerobics Center Longitudinal Study, Dallas, Texas, 1974−2003. The
reference group was the unfit group (the lowest 20% of the distribution of CRF). We used Cox
proportional hazard models to estimate the hazard ratio, which include age, examination year,
smoking, alcohol intake, personal history of diabetes, family history of cancer, and body mass
index as covariates. The error bars represent the 95% confidence intervals.
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